<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01509586</url>
  </required_header>
  <id_info>
    <org_study_id>Pro00007428</org_study_id>
    <secondary_id>R01CA154992</secondary_id>
    <nct_id>NCT01509586</nct_id>
  </id_info>
  <brief_title>A Test of Short and Long Term Naturalistic Outcomes of Smokers Who Sample Smokeless Tobacco</brief_title>
  <official_title>A Test of Short and Long Term Naturalistic Outcomes of Smokers Who Sample Smokeless Tobacco</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of South Carolina</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Medical University of South Carolina</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This nationwide telephone and mail- based research study will recruit 1,400 cigarette smokers
      who are not motivated to quit to test the effects of a marketed oral, non-combustible
      smokeless tobacco product on cigarette smoking behaviors. It will also track the
      participants' usage patterns of the smokeless tobacco product.

      Half of the participants will receive a new, potentially safer tobacco product during the
      first six weeks of the study, and half will not. During this six-week period, each
      participant will complete three brief phone interviews. After this first six week period,
      participants will complete 6 other brief follow-up interviews, where they will answer
      questionnaires about their smoking habits.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2011</start_date>
  <completion_date type="Actual">March 2016</completion_date>
  <primary_completion_date type="Actual">March 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Quit Attempts and Abstinence</measure>
    <time_frame>From study enrollment through end of one-year follow up</time_frame>
    <description>% of study participants making a quit attempt or staying abstinent from smoking during the study
Notes:
Floating abstinence: Any 7-day period of non-smoking, ever within study. PPA: point-prevalence abstinence</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">1236</enrollment>
  <condition>Smoking</condition>
  <condition>Smoking Cessation</condition>
  <arm_group>
    <arm_group_label>PREP (Potentially Reduced Exposure Product) Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>cigarette group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Potentially Reduced Exposure Product (PREP): a smokeless, spit-free tobacco product</intervention_name>
    <description>The PREP Group will be given a sample supply of a PREP product that is already on the market. It is unclear if it is safer than cigarettes, and that is why it is classified as a Potentially Reduced Exposure Product. It provides both nicotine and tobacco in the form of a pouch that can be thrown away after used. Unlike chewing tobacco, there is no need for spitting with this product. There are multiple flavors and participants will have his/her choice of preferred flavor. This group will be asked to sample the product and use it in several ways, but whether a participant uses the product or not is up him/her.</description>
    <arm_group_label>PREP (Potentially Reduced Exposure Product) Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age &gt;=19

          -  a daily cigarette smoker of &gt;=10 cigs/day

          -  English speaking

          -  live in the contiguous U.S.

          -  unmotivated to quit smoking in the next 30 days

        Exclusion Criteria:

          -  no use of smokeless tobacco in past six months

          -  not breastfeeding, pregnant, or planning a pregnancy

          -  devoid of any recent (past 6 months) cardiovascular trauma

          -  no quit attempt of &gt;=1 week in past 6 months

          -  no use of pharmacotherapy to quit smoking in past 3 months
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Matthew J. Carpenter, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical University of South Carolina</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Medical University of South Carolina</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29425</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 14, 2011</study_first_submitted>
  <study_first_submitted_qc>January 10, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 13, 2012</study_first_posted>
  <results_first_submitted>June 20, 2016</results_first_submitted>
  <results_first_submitted_qc>June 20, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">August 1, 2016</results_first_posted>
  <last_update_submitted>June 20, 2016</last_update_submitted>
  <last_update_submitted_qc>June 20, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 1, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>smoking</keyword>
  <keyword>smoking cessation</keyword>
  <keyword>Potentially Reduced Exposure Products (PREPs)</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lobeline</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>PREP (Potentially Reduced Exposure Product) Group</title>
          <description>Potentially Reduced Exposure Product (PREP): a smokeless, spit-free tobacco product: The PREP Group will be given a sample supply of a PREP product that is already on the market. It is unclear if it is safer than cigarettes, and that is why it is classified as a Potentially Reduced Exposure Product. It provides both nicotine and tobacco in the form of a pouch that can be thrown away after used. Unlike chewing tobacco, there is no need for spitting with this product. There are multiple flavors and participants will have his/her choice of preferred flavor. This group will be asked to sample the product and use it in several ways, but whether a participant uses the product or not is up him/her.</description>
        </group>
        <group group_id="P2">
          <title>Cigarette Group</title>
          <description>This group will smoke their normal cigarettes as much or as little as they want to.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="626">Week 0</participants>
                <participants group_id="P2" count="610">Week 0</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>Week 3</title>
              <participants_list>
                <participants group_id="P1" count="574"/>
                <participants group_id="P2" count="585"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Week 6</title>
              <participants_list>
                <participants group_id="P1" count="551"/>
                <participants group_id="P2" count="585"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Week 10</title>
              <participants_list>
                <participants group_id="P1" count="537"/>
                <participants group_id="P2" count="574"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Week 14</title>
              <participants_list>
                <participants group_id="P1" count="528"/>
                <participants group_id="P2" count="566"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Week18</title>
              <participants_list>
                <participants group_id="P1" count="529"/>
                <participants group_id="P2" count="555"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Week 32 (Month 6)</title>
              <participants_list>
                <participants group_id="P1" count="504"/>
                <participants group_id="P2" count="523"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Week 46</title>
              <participants_list>
                <participants group_id="P1" count="483"/>
                <participants group_id="P2" count="494"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Week 58 (Month 12)</title>
              <participants_list>
                <participants group_id="P1" count="492"/>
                <participants group_id="P2" count="499"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="626">final intent to treat sample</participants>
                <participants group_id="P2" count="610">final intent to treat sample</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>PREP (Potentially Reduced Exposure Product) Group</title>
          <description>Potentially Reduced Exposure Product (PREP): a smokeless, spit-free tobacco product: The PREP Group will be given a sample supply of a PREP product that is already on the market. It is unclear if it is safer than cigarettes, and that is why it is classified as a Potentially Reduced Exposure Product. It provides both nicotine and tobacco in the form of a pouch that can be thrown away after used. Unlike chewing tobacco, there is no need for spitting with this product. There are multiple flavors and participants will have his/her choice of preferred flavor. This group will be asked to sample the product and use it in several ways, but whether a participant uses the product or not is up him/her.</description>
        </group>
        <group group_id="B2">
          <title>Cigarette Group</title>
          <description>This group will smoke their normal cigarettes as much or as little as they want to.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="626"/>
            <count group_id="B2" value="610"/>
            <count group_id="B3" value="1236"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="48.7" spread="12.5"/>
                    <measurement group_id="B2" value="48.7" spread="12.6"/>
                    <measurement group_id="B3" value="48.7" spread="12.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="438"/>
                    <measurement group_id="B2" value="397"/>
                    <measurement group_id="B3" value="835"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="188"/>
                    <measurement group_id="B2" value="213"/>
                    <measurement group_id="B3" value="401"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Caucasian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="557"/>
                    <measurement group_id="B2" value="531"/>
                    <measurement group_id="B3" value="1088"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>African-American</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="56"/>
                    <measurement group_id="B2" value="61"/>
                    <measurement group_id="B3" value="117"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="18"/>
                    <measurement group_id="B3" value="31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Intend to quit smoking, next month</title>
          <description>0 - 10 scale, where 0 is no intent to quit and 10 is the most intent to quit smoking in the next 30 days</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1.4" spread="2.3"/>
                    <measurement group_id="B2" value="1.3" spread="2.4"/>
                    <measurement group_id="B3" value="1.4" spread="2.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Confidence to quit smoking</title>
          <description>0 -10 scale, where 0 is no confidence to quit smoking and 10 is the most confidence to quit smoking, in the next 30 days</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2.6" spread="3.1"/>
                    <measurement group_id="B2" value="2.7" spread="3.0"/>
                    <measurement group_id="B3" value="2.7" spread="3.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Cigarettes per day</title>
          <units>average cigarettes per day at baseline</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20.1" spread="8.7"/>
                    <measurement group_id="B2" value="19.9" spread="8.4"/>
                    <measurement group_id="B3" value="20.0" spread="8.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Quit Attempts and Abstinence</title>
        <description>% of study participants making a quit attempt or staying abstinent from smoking during the study
Notes:
Floating abstinence: Any 7-day period of non-smoking, ever within study. PPA: point-prevalence abstinence</description>
        <time_frame>From study enrollment through end of one-year follow up</time_frame>
        <group_list>
          <group group_id="O1">
            <title>PREP (Potentially Reduced Exposure Product) Group</title>
            <description>Potentially Reduced Exposure Product (PREP): a smokeless, spit-free tobacco product: The PREP Group will be given a sample supply of a PREP product that is already on the market. It is unclear if it is safer than cigarettes, and that is why it is classified as a Potentially Reduced Exposure Product. It provides both nicotine and tobacco in the form of a pouch that can be thrown away after used. Unlike chewing tobacco, there is no need for spitting with this product. There are multiple flavors and participants will have his/her choice of preferred flavor. This group will be asked to sample the product and use it in several ways, but whether a participant uses the product or not is up him/her.</description>
          </group>
          <group group_id="O2">
            <title>Cigarette Group</title>
            <description>This group will smoke their normal cigarettes as much or as little as they want to.</description>
          </group>
        </group_list>
        <measure>
          <title>Quit Attempts and Abstinence</title>
          <description>% of study participants making a quit attempt or staying abstinent from smoking during the study
Notes:
Floating abstinence: Any 7-day period of non-smoking, ever within study. PPA: point-prevalence abstinence</description>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="626"/>
                <count group_id="O2" value="610"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Any quit attempt, ever within study</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25.7"/>
                    <measurement group_id="O2" value="30.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any 24 h quit attempt, ever within study</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19.8"/>
                    <measurement group_id="O2" value="25.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Floating abstinence</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.9"/>
                    <measurement group_id="O2" value="16.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 32 PPA</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.2"/>
                    <measurement group_id="O2" value="5.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 58 PPA</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.1"/>
                    <measurement group_id="O2" value="5.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse events were asked to both groups at all 8 follow-up interviews (weeks 3, 6, 10, 14, 18, 32, 46, and 58). Numbers below are cumulative of all adverse events reported at all 8 follow-up interviews.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>PREP (Potentially Reduced Exposure Product) Group</title>
          <description>Potentially Reduced Exposure Product (PREP): a smokeless, spit-free tobacco product: The PREP Group will be given a sample supply of a PREP product that is already on the market. It is unclear if it is safer than cigarettes, and that is why it is classified as a Potentially Reduced Exposure Product. It provides both nicotine and tobacco in the form of a pouch that can be thrown away after used. Unlike chewing tobacco, there is no need for spitting with this product. There are multiple flavors and participants will have his/her choice of preferred flavor. This group will be asked to sample the product and use it in several ways, but whether a participant uses the product or not is up him/her.</description>
        </group>
        <group group_id="E2">
          <title>Cigarette Group</title>
          <description>This group will smoke their normal cigarettes as much or as little as they want to.</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="626"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="610"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Death</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="626"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="610"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="458" subjects_at_risk="626"/>
                <counts group_id="E2" subjects_affected="414" subjects_at_risk="610"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>nausea</sub_title>
                <counts group_id="E1" subjects_affected="93" subjects_at_risk="626"/>
                <counts group_id="E2" subjects_affected="82" subjects_at_risk="610"/>
              </event>
              <event>
                <sub_title>heartburn</sub_title>
                <counts group_id="E1" subjects_affected="68" subjects_at_risk="626"/>
                <counts group_id="E2" subjects_affected="51" subjects_at_risk="610"/>
              </event>
              <event>
                <sub_title>mouth soreness</sub_title>
                <counts group_id="E1" subjects_affected="46" subjects_at_risk="626"/>
                <counts group_id="E2" subjects_affected="43" subjects_at_risk="610"/>
              </event>
              <event>
                <sub_title>hiccups</sub_title>
                <counts group_id="E1" subjects_affected="44" subjects_at_risk="626"/>
                <counts group_id="E2" subjects_affected="21" subjects_at_risk="610"/>
              </event>
              <event>
                <sub_title>burning in throat/mouth</sub_title>
                <counts group_id="E1" subjects_affected="59" subjects_at_risk="626"/>
                <counts group_id="E2" subjects_affected="21" subjects_at_risk="610"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>headache</sub_title>
                <counts group_id="E1" subjects_affected="79" subjects_at_risk="626"/>
                <counts group_id="E2" subjects_affected="93" subjects_at_risk="610"/>
              </event>
              <event>
                <sub_title>dizziness or lightheadnedness</sub_title>
                <counts group_id="E1" subjects_affected="54" subjects_at_risk="626"/>
                <counts group_id="E2" subjects_affected="61" subjects_at_risk="610"/>
              </event>
              <event>
                <sub_title>dry mouth</sub_title>
                <counts group_id="E1" subjects_affected="53" subjects_at_risk="626"/>
                <counts group_id="E2" subjects_affected="57" subjects_at_risk="610"/>
              </event>
              <event>
                <sub_title>sore jaw</sub_title>
                <counts group_id="E1" subjects_affected="14" subjects_at_risk="626"/>
                <counts group_id="E2" subjects_affected="18" subjects_at_risk="610"/>
              </event>
              <event>
                <sub_title>excessive salivation</sub_title>
                <counts group_id="E1" subjects_affected="29" subjects_at_risk="626"/>
                <counts group_id="E2" subjects_affected="15" subjects_at_risk="610"/>
              </event>
              <event>
                <sub_title>insomnia</sub_title>
                <counts group_id="E1" subjects_affected="66" subjects_at_risk="626"/>
                <counts group_id="E2" subjects_affected="70" subjects_at_risk="610"/>
              </event>
              <event>
                <sub_title>other</sub_title>
                <counts group_id="E1" subjects_affected="338" subjects_at_risk="626"/>
                <counts group_id="E2" subjects_affected="332" subjects_at_risk="610"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Matthew J. Carpenter</name_or_title>
      <organization>Medical University of South Carolina</organization>
      <phone>843-876-2436</phone>
      <email>carpente@musc.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

